닫기

대한의료관련감염관리학회

View

Original Article

Korean J healthc assoc Infect Control Prev 2012; 17(2): 70-78

Published online December 30, 2012 https://doi.org/10.14192/kjicp.2012.17.2.70

Copyright © Korean Society for Healthcare-associated infection Control and Prevention

Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection:A Systematic Literature Review

JaHyun Kang

University of North Carolina at Chapel Hill, School of Nursing, NC, USA

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: Over the past several years, Clostridium difficile has become a major healthcare-associated pathogen. Fecal bacteriotherapy has been reported as an effective intervention for treating recurrent C. difficile infection by restoring the normal intestinal microbiota.
Methods: Articles on fecal bacteriotherapy were collected through PubMed, CINAHL, Cochrane Library, and Web of Science databases using the keywords "Clostridium difficile," "feces," "fecal transplantation," "fecal microbiota transplantation," and "fecal bacteriotherapy." Using a systematic literature review, variables of interest from articles that met the inclusion criteria were extracted and summarized.
Results: Among 141 articles that were published in English from January 1, 2000 to August 31, 2012, 8 studies were selected for analysis after assessing the titles, abstracts, and full contents. Fecal bacteriotherapy procedures varied with respect to donor selection, screening, infusion route, and preparation of the suspension. Donors were mostly family members or relatives, and donor screening included tests for blood borne and stool pathogens. Selected infusion routes were colonoscopy (62.5%), nasogastric tube (25%), and enema (12.5%). The success rate was reported to be 73-100%. There was a lack of a standard procedure for fecal bacteriotherapy in all of the selected studies.
Conclusion: Fecal bacteriotherapy is an effective intervention for combating C. difficile infection that has a high success rate and no adverse effects. This therapy would be helpful for infection control in hospital settings by facilitating early eradication of C. difficile infection.

Keywords: Clostridium difficile, Feces, Microbiota

Share this article on :

Related articles in KJICP

더보기

Sporicidal Activity of Selected Disinfectants against Clostridium difficile

Song Yi An, Woong Jung, Chang Min Lee, Sung Hyuk Park, Hyun Kyung Park, Myung Chun...

2011; 16(1): 13-17 https://doi.org/10.14192/kjicp.2011.16.1.13

Most KeyWord